Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study

International Journal of Pharmaceutics
Aly A Abdelbary, Mohamed H H AbouGhaly

Abstract

Psoriasis, a skin disorder characterized by impaired epidermal differentiation, is regularly treated by systemic methotrexate (MTX), an effective cytotoxic drug but with numerous side effects. The aim of this work was to design topical MTX loaded niosomes for management of psoriasis to avoid systemic toxicity. To achieve this goal, MTX niosomes were prepared by thin film hydration technique. A Box-Behnken (BB) design, using Design-Expert(®) software, was employed to statistically optimize formulation variables. Three independent variables were evaluated: MTX concentration in hydration medium (X1), total weight of niosomal components (X2) and surfactant: cholesterol ratio (X3). The encapsulation efficiency percent (Y1: EE%) and particle size (Y2: PS) were selected as dependent variables. The optimal formulation (F12) displayed spherical morphology under transmission electron microscopy (TEM), optimum particle size of 1375.00 nm and high EE% of 78.66%. In-vivo skin deposition study showed that the highest value of percentage drug deposited (22.45%) and AUC0-10 (1.15 mg.h/cm(2)) of MTX from niosomes were significantly greater than that of drug solution (13.87% and 0.49 mg.h/cm(2), respectively). Moreover, in-vivo histopathological...Continue Reading

References

Oct 1, 1990·Japanese Journal of Cancer Research : Gann·T IchinoJ Yura
Jan 29, 1990·Biochimica Et Biophysica Acta·W Abraham, D T Downing
Dec 1, 1985·The Journal of Pharmacy and Pharmacology·A J BaillieA Rogerson
Feb 1, 1989·Archives of Dermatology·G D WeinsteinE Olsen
May 20, 2003·International Journal of Pharmaceutics·D D VermaA Fahr
Aug 4, 2004·International Journal of Pharmaceutics·Gregorios G AgyralidesDimitrios M Rekkas
Oct 24, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Shruti ChopraSanjay K Motwani
Jan 26, 2007·Biomedical Microdevices·Donatella PaolinoMassimo Fresta
Jun 15, 2007·Indian Journal of Dermatology, Venereology and Leprology·P K LakshmiS Sacchidanand
Nov 28, 2007·The Journal of Experimental Medicine·Lisa C ZabaJames G Krueger
Jun 26, 2008·International Journal of Pharmaceutics·Mahmoud MokhtarNagia A Megrab
Mar 12, 2009·The Journal of Chemical Physics·Zilu Wang, Xuehao He
Apr 28, 2009·International Journal of Pharmaceutics·Prabagar BalakrishnanChul Soon Yong
Dec 23, 2009·Pharmaceutical Development and Technology·Ghada Abdelbary
Jul 17, 2010·AAPS PharmSciTech·Kandasamy Ruckmani, Veintramuthu Sankar
Sep 14, 2010·Colloids and Surfaces. B, Biointerfaces·Luisa Di MarzioMaria Carafa
Jan 14, 2011·The Journal of Investigative Dermatology·Rachael A Clark
Oct 1, 2010·Journal of Advanced Pharmaceutical Technology & Research·Karim Masud KaziKetousetuo Kuotsu
Oct 9, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Carlotta MarianecciMaria Carafa
Jan 29, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Anchal Sankhyan, Pravin K Pawar
May 22, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Nadia M MorsiMohammed A Ahmed
Jun 27, 2013·Journal of Chromatographic Science·Elias BegasEftihia Asprodini
Jul 23, 2013·International Journal of Pharmaceutics·Hema ChaudharyVikash Kumar
Nov 26, 2013·International Journal of Pharmaceutics·Li-Na ShenNian-Ping Feng
Apr 22, 2014·International Journal of Pharmaceutics·Ehab R Bendas, Aly A Abdelbary

❮ Previous
Next ❯

Citations

Jun 28, 2016·Expert Opinion on Drug Delivery·Eline DesmetJo Lambert
Sep 11, 2016·Materials Science & Engineering. C, Materials for Biological Applications·Seyedeh Raziyeh Mahdavi MoghddamYasmin Sultana
Sep 8, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Muhammad Imran KhanLeena Peltonen
Sep 16, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mihaela Violeta GhicaDenisa Ioana Udeanu
Feb 9, 2018·Drug Development and Industrial Pharmacy·Mahmoud S SolimanHossam S El-Sawy
Sep 14, 2018·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Maryam RameshkMehrnaz Mehrabani
Dec 7, 2018·Journal of Liposome Research·Rehab Nabil ShammaSolwan Ibrahim El-Samanoudy
Mar 29, 2019·Drug Development and Industrial Pharmacy·Magdy Ibrahim MohamedTamer Mohamed Mahmoud
Oct 11, 2019·Dermatologic Therapy·Giovanni DamianiNicola L Bragazzi
Apr 29, 2015·Artificial Cells, Nanomedicine, and Biotechnology·Tarun GargAmit K Goyal
Oct 1, 2020·Journal of Drug Targeting·Zaynab Sadeghi-GhadiAli Nokhodchi
Feb 18, 2020·Molecular Neurobiology·Ana M MartinsJoana Marto
Jan 18, 2019·Advances in Pharmacological Sciences·Mahmoud GharbaviAli Sharafi
May 21, 2019·Journal of Microencapsulation·Zaynab Sadeghi Ghadi, Pedram Ebrahimnejad
Jun 18, 2020·International Journal of Nanomedicine·Yun-Chun ZhaoCai-Hong Zheng
Jul 31, 2020·Pharmaceuticals·Pratheeksha Koppa RaghuNeelesh Kumar Mehra
Feb 8, 2020·Journal of Environmental Health Science & Engineering·Mahtab BaghebanMaryam Salimi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.